SCHEMBL30646100

SCHEMBL30646100

O=C1CCCCc2nc(Cl)ccc21

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 3/20 0.47
MAOA P21397 5/20 0.43
MAOB P27338 5/20 0.43
PARP1 P09874 2/20 0.38
ALDH1A1 P00352 2/20 0.38
NPSR1 Q6W5P4 2/20 0.38
PRKCI P41743 1/20 0.38
MAPT P10636 2/20 0.36
USP2 O75604 1/20 0.36
TSHR P16473 2/20 0.35
LMNA P02545 1/20 0.35
HTT P42858 1/20 0.35
KDM4E B2RXH2 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
TP53 P04637 1/20 0.35
NFKB1 P19838 1/20 0.35
NFKB2 Q00653 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29561825 0.96 GRM5 (0.51) GRM5MAOAMAOBALDH1A1NPSR1
SCHEMBL867309 0.96 GRM5 (0.51) GRM5MAOAMAOBALDH1A1NPSR1
SCHEMBL31069650 0.88 GRM5 (0.39) GRM5MAOAMAOBPARP1ALDH1A1
SCHEMBL21223432 0.88 GRM5 (0.39) GRM5MAOAMAOBPARP1ALDH1A1
SCHEMBL8630992 0.77 GRM5 (0.51) GRM5MAOAMAOBALDH1A1NPSR1
SCHEMBL930529 0.74 ADRA2A (0.46) GRM5MAOBNPSR1SMN1; SMN2
SCHEMBL23376905 0.73 GRM5 (0.51) GRM5MAOAMAOBALDH1A1NPSR1
SCHEMBL23376853 0.73 GRM5 (0.51) GRM5MAOAMAOBALDH1A1NPSR1
SCHEMBL23376904 0.73 GRM5 (0.51) GRM5MAOAMAOBALDH1A1NPSR1
SCHEMBL3894956 0.73 CYP2C19 (0.54) GRM5MAOAMAOBALDH1A1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4543437-A1 3-?HSD1 INHIBITORS AND COMPOSITIONS AND USES THEREOF THE CLEVELAND CLINIC FOUNDATION (US) 2025-04-30 EP disclosed
WO-2023250480-A1 3-βHSD1 INHIBITORS AND COMPOSITIONS AND USES THEREOF THE CLEVELAND CLINIC FOUNDATION (US) 2023-12-28 WO disclosed